The emerging functionality of endogenous lectins: A primer to the concept and a case study on galectins including medical implications

Chang Gung Medical Journal

Volumn 29, Issue 1 SPEC. ISS., 2006, Pages 37-62

  Gabius, Hans Joachim ^a   Wu, Albert M ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Agglutinin; Apoptosis; Drug design; Galectin; Glycoconjugate; Lectin; Metastasis; Sugar code

Indexed keywords

AMINO ACID; BETA GALACTOSIDASE; CARBOHYDRATE; GALECTIN; GALECTIN 1; GALECTIN 2; GALECTIN 3; GALECTIN 4; GALECTIN 7; GALECTIN 8; GANGLIOSIDE GM1; GLYCOLIPID; GLYCOPROTEIN; INTEGRIN; LECTIN; NUCLEIC ACID; NUCLEOTIDE; OLIGOMER; OLIGOSACCHARIDE; PROTEOGLYCAN;

APOPTOSIS; CANCER INHIBITION; CELL GROWTH; CELL INVASION; CELL MIGRATION; ENERGY METABOLISM; GENEALOGY; GENETIC CODE; GLYCOBIOLOGY; GROWTH REGULATION; HISTOPATHOLOGY; HUMAN; HYDROGEN BOND; INNATE IMMUNITY; MALIGNANT TRANSFORMATION; MICROPHOTOGRAPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; T LYMPHOCYTE; TUMOR CELL; TUMOR GROWTH;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CARBOHYDRATE CONFORMATION; DRUG DESIGN; GALECTINS; HUMANS; HYDROGEN BONDING; LIGANDS; MOLECULAR SEQUENCE DATA; OLIGOSACCHARIDES; PROTEIN CONFORMATION;

EID: 33645462356     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Sharon N. Lectins: from obscurity into the limelight. Protein Sci 1998;7:2042-8.
2. Laine RA. The information-storing potential of the sugar code. In: Gabius HJ, Gabius S, eds. Glycosciences: Status and Perspectives. London-Weinheim: Chapman & Hall, 1997:1-14.
3. Roseman S. Reflections on glycobiology. J Biol Chem 2001;276:41527-42.
4. Hounsell EF. Methods of glycoconjugate analysis. In: Gabius HJ, Gabius S, eds. Glycosciences: Status and Perspectives. London-Weinheim: Chapman & Hall, 1997:15-29.
5. Geyer H, Geyer R. Strategies for glycoconjugate analysis. Acta Anat 1998;161:18-35.
6. Kobata A. Structures and functions of the sugar chains of glycoproteins. Eur J Biochem 1992;209:483-501.
7. Sharon N, Lis H. Glycoproteins: structure and function. In: Gabius HJ, Gabius S, eds. Glycosciences: Status and Perspectives. London-Weinheim: Chapman & Hall, 1997:133-62.
8. Reuter G, Gabius HJ. Eukaryotic glycosylation: whim of nature or multipurpose tool? Cell Mol Life Sci 1999;55:368-422.
9. Gabius HJ. Animal lectins. Eur J Biochem 1997;243:543-76.
10. Szathmáry E. Why are there four letters in the genetic alphabet? Nat Rev Genet 2003;4:995-1001.
11. Brockhausen I, Schachter H. Glycosyltransferases involved in N- and O-glycan biosynthesis. In: Gabius HJ, Gabius S, eds. Glycosciences: Status and Perspectives. London-Weinheim: Chapman & Hall, 1997:79-113.
12. Gabius HJ, André S, Kaltner H, Siebert HC. The sugar code: functional lectinomics. Biochim Biophys Acta 2002;1572:165-77.
13. Spiro RG. Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 2002;12:43R-56R.
14. Lis H, Sharon N. Lectins: carbohydrate-specific proteins that mediate cellular recognition. Chem Rev 1998;98:637-74.
15. Rüdiger H, Gabius HJ. Plant lectins: occurrence, biochemistry, functions and applications. Glycoconj J 2001;18:589-613.
16. Mitchell SW. Researches upon the venom of the rattlesnake. Smithsonian Contributions to Knowledge 1860;XII:89-90.
17. Ogilvie ML, Gartner TK. Identification of lectins in snake venoms. J Herpetol 1984;18:285-90.
18. Sharon N, Lis H. The structural basis for carbohydrate recognition by lectins. Adv Exp Med Biol 2001;491:1-16.
19. Solís D, Jiménez-Barbero J, Kaltner H, Romero A, Siebert HC, von der Lieth CW, Gabius HJ. Towards defining the role of glycans as hardware in information storage and transfer: basic principles, experimental approaches and recent progress. Cells Tissues Organs 2001;168:5-23.
20. Linehan SA, Marínez-Pomares L, Gordon S. Macrophage lectins in host defence. Microbes Infect 2000;2:279-88.
21. Kilpatrick DC. Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta 2002;1572:401-13.
22. Gabius HJ. (ed.) Special issue on animal lectins. Biochim Biophys Acta 2002;1572:163-434.
23. Wu AM. Carbohydrate structural units in glycosphingolipids as receptors for Gal and GalNAc reactive lectins. Neurochem Res 2002;27:593-600.
24. Wu AM. Carbohydrate structural units in glycoproteins and polysaccharides as important ligands for Gal and GalNAc reactive lectins. J Biomed Sci 2003;10:676-88.
25. Winterburn PJ, Phelps CF. The significance of glycosylated proteins. Nature 1972;236:147-51.
26. Hennet T. The galactosyltransferase family. Cell Mol Life Sci 2002;59:1081-95.
27. Teichberg VI, Silman I, Beitsch DD, Resheff G. A β-D-galactoside binding protein from electric organ tissue of Electrophorus electricus. Proc Natl Acad Sci USA 1975:72:1383-7.
28. Cooper DN. Galectinomics: finding themes in complexity. Biochim Biophys Acta 2002;1572:209-31.
29. Gabius HJ, Brehler R, Schauer A, Cramer F. Localization of endogenous lectins in normal human breast, benign breast lesions and mammary carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol 1986;52:107-15.
30. Lahm H, André S, Höeflich A, Fischer JR, Sordat B, Kaltner H, Wolf E, Gabius HJ. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol 2001;127:375-86.
31. Lahm H, André S, Hoeflich A, Fischer JR, Sordat B, Kaltner H, Wolf E, Gabius HJ. Molecular biological fingerprinting of human lectin expression by RT-PCR. Methods Enzymol 2003;362:287-97.
32. Nagy N, Legendre H, Engels O, André S, Kaltner H, Wasano K, Zick Y, Pector JC, Decaestecker C, Gabius HJ, Salmon I, Kiss R. Refined prognostic evaluation in colon carcenoma using immunohistochemical galectin fingerprinting. Cancer 2003;97:1849-58.
33. Camby I, Belot N, Lefranc F, Sadeghi N, de Launoit Y, Kaltner H, Musette S, Darro F, Danguy A, Salmon I, Gabius HJ, Kiss R. Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol 2002;61:585-96.
34. Gabius HJ. Probing the cons and pros of lectin-induced immunomodulation: case studies for the mistletoe lectin and galectin-1. Biochimie 2001;83:659-66.
35. Kopitz J, von Reitzenstein C, André S, Kaltner H, Uhl J, Ehemann V, Cantz M, Gabius HJ. Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J Biol Chem 2001;276:35917-23.
36. Kopitz J, André S, von Reitzenstein C, Versluis K, Kaltner H, Pieters RJ, Wasano K, Kuwabara I, Liu FT, Cantz M, Heck AJ, Gabius HJ. Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells. Oncogene 2003;22:6277-88.
37. 1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture. J Biol Chem 1998;273:11205-11.
38. Brewer CF. Lectin cross-linking interactions with multivalent carbohydrates. Adv Exp Med Biol 2001;491:17-25.
39. Fred Brewer C. Binding and cross-linking properties of galectins. Biochim Biophys Acta 2002;1572:255-62.
40. Gabius HJ, André S, Danguy A, Kayser K, Gabius S. Detection and quantification of carbohydrate-binding sites on cell surfaces and on tissue sections by neoglycoproteins. Methods Enzymol 1994;242:37-46.
41. Gargir A, Shtevi A, Gortler M, Dukler A, Dotan N. GlycoChip™- high throughput technology for screening and analysis of protein-glycan interactions. Glycoconj J 2001;18:26, Abstr. C1.20.
42. Bryan MC, Plettenbutg O, Sears P, Rabuka D, Wacowich-Sgarbi S, Wong CH. Saccharide display on microtiter plates. Chem Biol 2002;9:713-20.
43. Duk M, Lisowska E, Wu JH, Wu AM. The biotin/avidin-mediated microtiter plate lectin assay with the use of chemically modified glycoprotein ligand. Anal Biochem 1994;221:266-72.
44. Wu AM, Wu JH, Chen Y, Tsai M, Herp A. Forssman pentasaccharide and polyvalent Galβ1→4GlcNAc as major ligands with affinity for Caragana arborescens agglutinin. FEBS Lett 1999;463:225-30.
45. Wu AM, Song SC, Chen YY, Gilboa-Garber N. Defining the carbohydrate specificities of aplysia gonad lectin exhibiting a peculiar D-galactouronic acid affinity. J Biol Chem 2000;275:14017-24.
46. Wu AM, Wu JH, Liu JH, Singh T, André S, Kaltner H, Gabius HJ. Effects of polyvalency of glycotopes and natural modifications of human blood group ABH/Lewis sugars at the Galβ1-terminated core saccharides on the binding of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N). Biochimie 2004;86:317-26.
47. b, I and i active glycoproteins purified from human ovarian cyst fluid. Adv Exp Med Biol 1988;228:351-94.
48. Wu AM, Lin SR, Chin LK, Chow LP, Lin JY. Defining the carbohydrate specificities of Abrus precatorious agglutinin as T (Galβ1→3GalNAc) greater than I/II (Gal β1→3/4GlcNAc). J Biol Chem 1992;267:19130-9.
49. Wu AM, Song SC, Chang SC, Wu JH, Chang KS, Kabat EA. Further characterization of the binding properties of a GalNAc specific lectin from Codium fragile subspecies tomentosoides. Glycobiology 1997;7:1061-6.
50. Wu AM, Wu JH, Tsai MS, Kaltner H, Gabius HJ. Carbohydrate specificity of a galectin from chicken liver (CG-16). Biochem J 2001;358:529-38.
51. Wu AM, Wu JH, Tsai MS, Liu JH, André S, Wasano K, Kaltner H, Gabius HJ. Fine specificity of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N). Biochem J 2002;367:653-64.
52. Ahmad N, Gabius HJ, Kaltner H, André S, Kuwabara I, Liu FT, Oscarson S, Norberg T, Brewer CF. Thermodynamic binding studies of cell surface carbohydrate epitopes to galectin-1, -3 and -7: Evidence for differential binding specificities. Can J Chem 2002;80:1096-104.
53. Gabius HJ, Siebert HC, André S, Jiménez-Barbero J, Rüdiger H. Chemical biology of the sugar code. Chem Bio Chem 2004;5:740-64.
54. Fischer E. Einfluss der Configuration auf die Wirkung der Enzyme. Ber Dt Chem Ces 1894;27:2985-93.
55. Hardy BJ. The glycosidic linkage flexibility and timescale similarity hypotheses. J Mol Struct 1997;395-396:187-200.
56. Gabius HJ. The how and why of protein-carbohydrate interaction: a primer to the theoretical concept and a guide to application in drug design. Pharm Res 1998;15:23-30.
57. Siebert HC, André S, Lu SY, Frank M, Kaltner H, van Kuik JA, Korchagina EY, Bovin N, Tajkhorshid E, Kaptein R, Vliegenthart JF, von der Lieth CW, Jiménez-Barbero J, Kopitz J, Gabius HJ. Unique conformer selection of human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins. Biochemistry 2003;42:14762-73.
58. André S, Unverzagt C, Kojima S, Dong X, Fink C, Kayser K, Gabius HJ. Neoglycoproteins with the synthetic complex biantennary nonasaccharide or its α2,3/α2,6-sialylated derivatives: their preparation, assessment of their ligand properties for purified lectins, for tumor cells in vitro, and in tissue sections, and their biodistribution in tumor-bearing mice. Bioconjug Chem 1997;8:845-55.
59. Unverzagt C, Andre S, Seifert J, Kojima S, Fink C, Srikrishna G, Freeze H, Kayser K, Gabius HJ. Structure-activity profiles of complex biantennary glycans with core fucosylation and with/without additional α2,3/α2,6 sialylation: synthesis of neoglycoproteins and their properties in lectin assays, cell binding, and organ uptake. J Med Chem 2002;45:478-91.
60. André S, Unverzagt C, Kojima S, Frank M, Seifert J, Fink C, Kayser K, von der Lieth CW, Gabius HJ. Determination of modulation of ligand properties of synthetic complex-type biantennary N-glycans by introduction of bisecting GlcNAc in silico, in vitro and in vivo. Eur J Biochem 2004;271:118-34.
61. Lee RT, Lee YC. Neoglycoconjugates. In: Gabius HJ, Gabius S, eds. Glycosciences: Status and Perspectives. London-Weinheim: Chapman & Hall, 1997:55-77.
62. Yamazaki N, Kojima S, Bovin NV, André S, Gabius S, Gabius HJ. Endogenous lectins as targets for drug delivery. Adv Drug Deliv Rev 2000;43:225-44.
63. Brockhausen I, Schutzbach J, Kuhns W. Glycoproteins and their relationship to human disease. Acta Anat 1998;161:36-78.
64. 1-acid glycoprotein (orosomucoid) in health and disease: occurrence, regulation and possible functional implications. Trends Glycosci Glycotechnol 1998;10:235-45.
65. Hakomori S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA 2002;99:10231-3.
66. Bovin NV, Gabius HJ. Polymer-immobilized carbohydrate ligands: versatile chemical tools for biochemistry and medical sciences. Chem Soc Rev 1995;24:413-21.
67. Roy R. A decade of glycodendrimer chemistry. Trends Glycosci Glycotechnol 2003;15:291-310.
68. Vrasidas I, André S, Valentini P, Böck C, Lensch M, Kaltner H, Liskamp RM, Gabius HJ, Pieters RJ. Rigidified multivalent lactose molecules and their interactions with mammalian galectins: a route to selective inhibitors. Org Biomol Chem 2003;1:803-10.
69. Gabius HJ. Glycohistochemistry: the why and how of detection and localization of endogenous lectins. Anat Histol Embryol 2001;30:3-31.
70. Wu JH, Song SC, Chen YY, Tsai MC, Kabat EA, Wu AM. Multi-antennary Galβ1-4GlcNAc and Galβ1-3GalNAc clusters as important ligands for a lectin isolated from the sponge Geodia cydonium. FEBs Lett 1998;427:134-8.